Laurel Grove Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $621K | Buy |
8,037
+282
| +4% | +$21.8K | 0.31% | 66 |
|
|
2018
Q2 | $549K | Sell |
7,755
-1,000
| -11% | -$70.8K | 0.29% | 76 |
|
|
2018
Q1 | $660K | Sell |
8,755
-250
| -3% | -$18.8K | 0.35% | 67 |
|
|
2017
Q4 | $645K | Sell |
9,005
-4,120
| -31% | -$295K | 0.33% | 71 |
|
|
2017
Q3 | $1.06M | Buy |
13,125
+375
| +3% | +$30.4K | 0.55% | 56 |
|
|
2017
Q2 | $902K | Sell |
12,750
-3,600
| -22% | -$255K | 0.48% | 57 |
|
|
2017
Q1 | $1.11M | Buy |
16,350
+700
| +4% | +$47.5K | 0.59% | 49 |
|
|
2016
Q4 | $1.12M | Buy |
15,650
+2,200
| +16% | +$158K | 0.61% | 48 |
|
|
2016
Q3 | $1.06M | Sell |
13,450
-600
| -4% | -$47.5K | 0.61% | 51 |
|
|
2016
Q2 | $1.17M | Sell |
14,050
-5,500
| -28% | -$459K | 0.7% | 45 |
|
|
2016
Q1 | $1.8M | Buy |
19,550
+4,750
| +32% | +$436K | 1.02% | 35 |
|
|
2015
Q4 | $1.5M | Buy |
14,800
+9,150
| +162% | +$926K | 0.84% | 44 |
|
|
2015
Q3 | $555K | Buy |
5,650
+2,550
| +82% | +$250K | 0.32% | 69 |
|
|
2015
Q2 | $363K | Sell |
3,100
-100
| -3% | -$11.7K | 0.19% | 87 |
|
|
2015
Q1 | $314K | Buy |
3,200
+500
| +19% | +$49.1K | 0.17% | 89 |
|
|
2014
Q4 | $255K | Hold |
2,700
| – | – | 0.15% | 86 |
|
|
2014
Q3 | $287K | Sell |
2,700
-100
| -4% | -$10.6K | 0.16% | 81 |
|
|
2014
Q2 | $232K | Sell |
2,800
-1,000
| -26% | -$82.9K | 0.13% | 85 |
|
|
2014
Q1 | $269K | Buy |
3,800
+800
| +27% | +$56.6K | 0.16% | 85 |
|
|
2013
Q4 | $225K | Buy |
+3,000
| New | +$225K | 0.13% | 89 |
|